| # | Drug | Count |
|---|---|---|
| 0 | RIOCIGUAT | 6 |
| 1 | ADALIMUMAB | 5 |
| 2 | DUPILUMAB | 4 |
| 3 | GABAPENTIN | 4 |
| 4 | MACITENTAN | 3 |
| 5 | MAGNESIUM | 3 |
| 6 | VENETOCLAX | 3 |
| 7 | ACETAMINOPHEN | 2 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 9 | ASPIRIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 1 | TRIHEPTANOIN | 1 | 0.0018 |
| 2 | RILONACEPT | 1 | 0.0009 |
| 3 | VUTRISIRAN | 2 | 0.0007 |
| 4 | EFGARTIGIMOD ALFA | 2 | 0.0005 |
| 5 | TIOTROPIUM BROMIDE AND OLODATEROL | 2 | 0.0004 |
| 6 | BRENSOCATIB | 1 | 0.0004 |
| 7 | PATISIRAN | 1 | 0.0004 |
| 8 | CEFIXIME | 1 | 0.0003 |
| 9 | BELUMOSUDIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 2 | Soluble Guanylate Cyclase Stimulator [EPC] | 6 | 0.0002 |
| 3 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 6 | Potassium Binder [EPC] | 1 | 0.0001 |
| 7 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 8 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |